β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice-Reference-Cited by-同舟云学术

β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice

Published:2019-11 Issue:46 Volume:294 Page:17524-17542
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zhang Weiqi,Meyfeldt Jennifer,Wang Huabo^ORCID,Kulkarni Sucheta,Lu Jie,Mandel Jordan A.,Marburger Brady,Liu Ying,Gorka Joanna E.,Ranganathan Sarangarajan,Prochownik Edward V.^ORCID

Funder

Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels

HHS | NIH | National Cancer Institute

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference90 articles.

1. Malignant tumors of the liver in children;Aronson;Semin. Pediatr. Surg,2016

2. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy;Czauderna;Curr. Opin. Pediatr,2014

3. Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt/β-catenin perspective;Bell;Gene Expr,2017

4. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group;Meyers;Pediatr. Blood Cancer,2009

5. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration;Meyers;Lancet Oncol,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When the Belly Looks Okay but Is Actually Not: A Case of Hepatoblastoma in a Well-Appearing Child;Cureus;2024-06-01

2. Lessons in aging from Myc knockout mouse models;Frontiers in Cell and Developmental Biology;2023-08-09

3. Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation;Cell Reports;2023-08

4. Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma;Nature Communications;2023-07-06

5. Elevated serum uric acid is associated with the risk of advanced staging and vascular involvement in patients with hepatoblastoma: a 14-year retrospective study;Frontiers in Oncology;2023-04-14